Virtual ISPOR Europe 2021: Realizing the potential of real-world data and evidence: how can pharmaceutical companies optimise through capabilities, structure and governance? – day 4 highlights

3 Dec 2021

Written by Darcy Hodge, Editor

Events coverage Health economics ISPOR Methodology Rare diseases and orphan drugs Stakeholder engagement

It is the final day of Virtual ISPOR Europe 2021 (30 November–3 December)! Don’t succumb to conference blues yet, as I’m still providing you with daily coverage. Read on for the panels and workshops that happened today. You can view the virtual conference program, concerning RWE optimization in the pharma industry, retrospective studies in rare diseases and plenty more. All of the sessions, posters and latest information from Virtual ISPOR Europe 2021 are available to view online. Click here >> In addition to our daily coverage, find more content from us as a media partner of Virtual ISPOR Europe 2021....